BPC-157 vs KPV
BPC-157 and KPV are often mentioned together because both are studied in gut and tissue research, but they come from different sources and have been investigated through different mechanisms. BPC-157 is a 15-amino-acid peptide based on a sequence found in a protein from gastric juice, and it has been studied mainly in rodent models of tissue injury and repair. KPV is a tripeptide, the three amino acids at the end of alpha-melanocyte-stimulating hormone, and it has been studied mainly for its effects on inflammatory signalling.
Put simply, BPC-157 research tends to focus on repair processes such as angiogenesis and tissue healing, while KPV research tends to focus on inflammatory pathways such as NF-kB in intestinal and skin models. This page compares their structure, research areas, status and handling. Both are research compounds supplied by PRIME for laboratory research use only.
| Attribute | BPC-157 | KPV |
|---|---|---|
| Compound class | Synthetic peptide | Synthetic tripeptide |
| Origin | Based on a sequence from a protein found in gastric juice | C-terminal fragment of alpha-MSH |
| Structure | Linear peptide of 15 amino acids | Lys-Pro-Val |
| Mechanism studied | Angiogenesis, nitric oxide signalling, growth factor pathways in tissue repair models | Suppression of inflammatory signalling, including NF-kB, in cell and rodent models |
| Main research areas | Tendon, ligament, muscle and gastrointestinal injury models | Intestinal inflammation models, epithelial uptake via PepT1, skin inflammation models |
| Research status | Research compound; not an approved medicine in the US | Research compound; not an approved medicine in the US |
| Form supplied | Lyophilized powder | Lyophilized powder |
| Storage | Cold, dry and protected from light; refrigerate after reconstitution | Cold, dry and protected from light; refrigerate after reconstitution |
BPC-157: a gastric-derived peptide studied in tissue repair
BPC-157, short for Body Protection Compound 157, is a synthetic peptide of 15 amino acids. Its sequence is taken from a larger protein found in human gastric juice, and it is notable among research peptides for its reported stability in gastric conditions. BPC-157 is a research compound and is not an approved medicine in the US.
Most of the published research on BPC-157 comes from rodent studies of injury and repair. These have looked at tendon, ligament, muscle and bone models, as well as models of damage to the stomach and intestinal lining. Mechanistic work has examined its relationship with angiogenesis, the formation of new blood vessels, with the nitric oxide system, and with growth factor signalling pathways involved in cell migration and tissue remodelling.
Because so much of its literature is preclinical and comes from a limited number of research groups, many researchers see BPC-157 as a compound where careful, independent study design is especially valuable. It is also frequently compared with other repair-focused peptides, most notably TB-500.
PRIME supplies BPC-157 research peptide as a lyophilized powder for laboratory use, and each batch has a published lab report so identity and purity can be checked before work begins.
KPV: an alpha-MSH tripeptide studied in inflammation
KPV is a tripeptide with the sequence lysine-proline-valine. It corresponds to the final three amino acids of alpha-melanocyte-stimulating hormone (alpha-MSH), a hormone known for its role in pigmentation and for its anti-inflammatory activity in research models. KPV is a research compound and is not an approved medicine in the US.
Research interest in KPV comes from the observation that this small fragment appears to retain much of the anti-inflammatory activity studied in the parent hormone, without the pigmentation-related activity associated with melanocortin receptor MC1 signalling. Cell and rodent studies have examined how KPV affects inflammatory signalling, with particular attention to the NF-kB pathway and the production of inflammatory cytokines.
A significant share of KPV research has focused on intestinal inflammation models. Studies have reported that KPV can be taken up by intestinal epithelial cells through the PepT1 peptide transporter, which has made it a subject of interest in gut-targeted delivery research, including nanoparticle formulations. Skin inflammation and wound models have also been explored.
Researchers can source KPV research peptide from PRIME as a lyophilized powder, with batch documentation available for each lot.
The better fit depends on whether a study is centred on repair or on inflammation. BPC-157 suits research questions about tissue healing, angiogenesis, nitric oxide signalling and recovery of tendon, ligament, muscle or gastrointestinal tissue in injury models. KPV suits research questions about inflammatory signalling, NF-kB activity, cytokine production and peptide transport in intestinal epithelium, as well as skin inflammation models.
In gut research the two can overlap, since BPC-157 has been studied in models of mucosal damage and KPV in models of intestinal inflammation. In that case, the endpoints usually decide the choice: structural repair measures point towards BPC-157, inflammatory markers towards KPV. See the BPC-157 research guide and the KPV peptide research guide for more background, and the BPC-157 vs TB-500 comparison if repair peptides are the focus.
Confirm identity and purity for each lot on the PRIME lab results page before starting an experiment.
For laboratory research use only. Not for human consumption.
Shop these compounds
What is the difference between BPC-157 and KPV?
BPC-157 is a 15-amino-acid peptide based on a gastric protein sequence, studied mainly in tissue injury and repair models. KPV is a three-amino-acid fragment of alpha-MSH, studied mainly for its effects on inflammatory signalling. They differ in size, origin and the mechanisms researchers investigate.
Where does KPV come from?
KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, made up of lysine, proline and valine. Research has examined whether this fragment keeps the anti-inflammatory activity studied in the full hormone.
Are BPC-157 and KPV approved drugs?
No. Both are research compounds and neither is an approved medicine in the US. PRIME sells them for laboratory research use only.
How should BPC-157 and KPV be handled in the lab?
Both are supplied as lyophilized powders kept cold, dry and away from light. For laboratory work they are typically reconstituted with bacteriostatic water, then refrigerated and used within the timeframe set by the lab's own protocols.